Assenagon Asset Management S.A. Sells 211,927 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Assenagon Asset Management S.A. decreased its position in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 39.5% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 323,982 shares of the medical device company's stock after selling 211,927 shares during the quarter. Assenagon Asset Management S.A. owned 0.16% of Cooper Companies worth $35,748,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently bought and sold shares of the company. LRI Investments LLC lifted its position in Cooper Companies by 4.5% in the 2nd quarter. LRI Investments LLC now owns 2,595 shares of the medical device company's stock worth $227,000 after buying an additional 112 shares during the last quarter. Mitchell & Pahl Private Wealth LLC lifted its position in Cooper Companies by 1.5% in the third quarter. Mitchell & Pahl Private Wealth LLC now owns 7,986 shares of the medical device company's stock valued at $881,000 after purchasing an additional 117 shares during the last quarter. Commonwealth Equity Services LLC lifted its position in Cooper Companies by 0.8% in the second quarter. Commonwealth Equity Services LLC now owns 15,600 shares of the medical device company's stock valued at $1,362,000 after purchasing an additional 118 shares during the last quarter. Bleakley Financial Group LLC lifted its position in Cooper Companies by 2.1% in the third quarter. Bleakley Financial Group LLC now owns 5,767 shares of the medical device company's stock valued at $636,000 after purchasing an additional 119 shares during the last quarter. Finally, First Horizon Advisors Inc. lifted its position in Cooper Companies by 4.8% in the second quarter. First Horizon Advisors Inc. now owns 2,709 shares of the medical device company's stock valued at $236,000 after purchasing an additional 125 shares during the last quarter. Institutional investors own 24.39% of the company's stock.

Insider Transactions at Cooper Companies

In related news, CEO Albert G. White III sold 114,992 shares of the stock in a transaction on Thursday, September 19th. The stock was sold at an average price of $110.53, for a total transaction of $12,710,065.76. Following the sale, the chief executive officer now directly owns 165,273 shares of the company's stock, valued at $18,267,624.69. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In related news, CEO Albert G. White III sold 114,992 shares of the stock in a transaction on Thursday, September 19th. The stock was sold at an average price of $110.53, for a total transaction of $12,710,065.76. Following the sale, the chief executive officer now directly owns 165,273 shares of the company's stock, valued at $18,267,624.69. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CAO Agostino Ricupati sold 1,601 shares of the stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $108.03, for a total value of $172,956.03. Following the sale, the chief accounting officer now directly owns 4,818 shares in the company, valued at $520,488.54. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 256,373 shares of company stock valued at $27,637,427. Insiders own 2.00% of the company's stock.

Cooper Companies Stock Up 0.5 %

Shares of NASDAQ COO traded up $0.52 during trading on Friday, reaching $107.82. The company had a trading volume of 3,270,373 shares, compared to its average volume of 1,128,228. The Cooper Companies, Inc. has a 12-month low of $75.93 and a 12-month high of $112.38. The stock has a market cap of $21.47 billion, a PE ratio of 63.20, a P/E/G ratio of 2.56 and a beta of 0.98. The business's 50-day moving average is $105.46 and its 200 day moving average is $96.66. The company has a quick ratio of 1.18, a current ratio of 1.99 and a debt-to-equity ratio of 0.33.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its earnings results on Wednesday, August 28th. The medical device company reported $0.96 EPS for the quarter, topping analysts' consensus estimates of $0.91 by $0.05. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. The firm had revenue of $1 billion for the quarter, compared to analysts' expectations of $997.30 million. During the same period in the prior year, the firm posted $0.84 earnings per share. The company's quarterly revenue was up 7.8% on a year-over-year basis. As a group, equities analysts forecast that The Cooper Companies, Inc. will post 3.65 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on COO shares. Morgan Stanley boosted their price objective on Cooper Companies from $95.00 to $104.00 and gave the company an "equal weight" rating in a research report on Tuesday, September 10th. Piper Sandler boosted their price objective on Cooper Companies from $115.00 to $120.00 and gave the company an "overweight" rating in a research report on Thursday, August 29th. Jefferies Financial Group upgraded Cooper Companies from a "hold" rating to a "buy" rating and boosted their price objective for the company from $107.00 to $115.00 in a research report on Tuesday, July 16th. Stifel Nicolaus restated a "buy" rating and set a $115.00 target price (up previously from $110.00) on shares of Cooper Companies in a report on Thursday, August 29th. Finally, Wells Fargo & Company upped their target price on Cooper Companies from $110.00 to $115.00 and gave the company an "overweight" rating in a report on Thursday, August 29th. Three equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company's stock. According to MarketBeat, Cooper Companies presently has a consensus rating of "Moderate Buy" and an average target price of $115.00.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.